On July 29, SENSETIME-W rose 3.57% in regular trading, trading at HK$1.45/share, with turnover of HK$652 million.

On the news front, SenseTime Medical recently completed a B-round financing exceeding US$100 million, becoming the first medical world model company with a valuation surpassing 10 billion yuan. Investors include Lianchuang Capital, China Electronics Digital Financing Fund, and Lianmei Group, among other institutional investors.

Meanwhile, the company released its flagship model SenseNova U1 Pro during WAIC and secured multiple strategic partnerships. The MaaS model invocation business continues to show strong growth momentum, with Goldman Sachs forecasting that SENSETIME-W will achieve EBITDA breakeven. These multiple positive catalysts have driven the stock to extend its recent upward trend, following gains of 3.03% on July 27 and 3.7% on July 28.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)